SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD Pathway)

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
BPS-79806	1 ml (2 x 500 µl)		-	-	3 - 15 business days*		1,373.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

The SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD signaling pathway) are replication... more

Close menu

Product information "SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD Pathway)"

The SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD signaling pathway) are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by multimerized SBE-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the TGFbeta/SMAD signaling pathway can be monitored by measuring the luciferase activity.

Keywords:	SBE reporter, TGFbeta reporter, TGFbeta reporter, SMAD reporter,
Supplier:	BPS Bioscience
Supplier-Nr:	79806

Properties

Application:	TGFbeta/SMAD signaling pathway activator / inhibitor screening, stable cell line generation
Species reactivity:	human

Database Information

KEGG ID :	K04674 \| Matching products
UniProt ID :	P36897 \| Matching products
Gene ID :	GeneID 7046 \| Matching products

Handling & Safety

Storage:	-80°C
Shipping:	-80°C (International: °C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "SBE Luciferase Reporter Lentivirus (TGFbeta/SMAD Pathway)"

Write a review